Rising elderly cancer burden to expand T-cell malignancies market

Advances in molecular profiling help improve the understanding of these diseases.

The T-cell malignancies market growth is expected to accelerate at a compound annual growth rate of 5.2% from 2026 to 2036, according to a DelveInsight report.

The report linked this to the rising burden of T-cell malignancies, especially amongst the elderly population, with the United States recording 15,500 new cases in 2025.

T-cell malignancies are a diverse group of cancers that arise from abnormal or uncontrolled growth of T lymphocytes, a type of white blood cell that plays a central role in the body's immune defence.

The report noted that advances in molecular profiling and immunotherapy are helping to improve understanding of these diseases and are driving the development of targeted therapies, novel antibodies, CAR-T approaches, and epigenetic treatments.